首页> 外国专利> COMPOSITIONS AND METHODS FOR TREATMENT OF THE SIDE-EFFECTS ASSOCIATED WITH ADMINISTRATION OF CANCER CHEMOTHERAPEUTIC AGENTS

COMPOSITIONS AND METHODS FOR TREATMENT OF THE SIDE-EFFECTS ASSOCIATED WITH ADMINISTRATION OF CANCER CHEMOTHERAPEUTIC AGENTS

机译:用于治疗与化疗药物相关的副作用的组合物和方法

摘要

A composition and method for the treatment of the side-effects associated with the administration of cancer chemotherapeutic agents involves the oral ingestion of a slow release capsule containing adenine and orotate. The administration of a protein pump inhibitor decreases systemic absorption of orotate and the administration of allopurinol decreases the formation of 2,8-dihydroxy adenine from adenine. In an alternative embodiment, cationic liposomes contain purine/pyrimidine precursors. The cationic liposomes bind to the cells lining the mucosa of the intestinal tract and then the contents of the cationic liposome are then taken up in the interior of the cells to prevent the metabolism of the cancer treatment drug 5-FU into a toxic species.
机译:用于治疗与癌症化学治疗剂的给药有关的副作用的组合物和方法涉及口服摄入含有腺嘌呤和乳清酸盐的缓释胶囊。蛋白质泵抑制剂的施用减少了乳清酸盐的全身吸收,而别嘌醇的施用减少了由腺嘌呤形成的2,8-二羟基腺嘌呤。在另一个实施方案中,阳离子脂质体含有嘌呤/嘧啶前体。阳离子脂质体与肠粘膜内壁的细胞结合,然后将阳离子脂质体的内容物吸收到细胞内部,以防止癌症治疗药物5-FU代谢为有毒物质。

著录项

  • 公开/公告号EP2836217A1

    专利类型

  • 公开/公告日2015-02-18

    原文格式PDF

  • 申请/专利权人 ASYMMETRIC THERAPEUTICS LLC;

    申请/专利号EP20130775759

  • 发明设计人 FORD JOHN P.;

    申请日2013-04-12

  • 分类号A61K31/70;A61K31/415;A61K31/52;A61P35;

  • 国家 EP

  • 入库时间 2022-08-21 15:03:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号